rs141990258
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005751.5(AKAP9):āc.4927A>Cā(p.Ile1643Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,613,628 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_005751.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKAP9 | NM_005751.5 | c.4927A>C | p.Ile1643Leu | missense_variant | 19/50 | ENST00000356239.8 | NP_005742.4 | |
AKAP9 | NM_147185.3 | c.4927A>C | p.Ile1643Leu | missense_variant | 19/50 | NP_671714.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AKAP9 | ENST00000356239.8 | c.4927A>C | p.Ile1643Leu | missense_variant | 19/50 | 1 | NM_005751.5 | ENSP00000348573.3 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152084Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251160Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135742
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461544Hom.: 0 Cov.: 30 AF XY: 0.0000289 AC XY: 21AN XY: 727086
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152084Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74264
ClinVar
Submissions by phenotype
AKAP9-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 26, 2023 | The AKAP9 c.4927A>C variant is predicted to result in the amino acid substitution p.Ile1643Leu. This variant was reported in an individual with sudden infant death, and was also present in the unaffected mother and sibling (Campuzano et al. 2014. PubMed ID: 25016126). This variant is reported in 0.012% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 04, 2021 | Reported in a patient with sudden infant death syndrome (SIDS) who also harbored additional cardiogenetic variants (Campuzano et al., 2014); Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 190485; Landrum et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 25016126) - |
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 01, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 190485). This variant has not been reported in the literature in individuals affected with AKAP9-related conditions. This variant is present in population databases (rs141990258, gnomAD 0.009%). This sequence change replaces isoleucine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 1643 of the AKAP9 protein (p.Ile1643Leu). - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2024 | The p.I1643L variant (also known as c.4927A>C), located in coding exon 19 of the AKAP9 gene, results from an A to C substitution at nucleotide position 4927. The isoleucine at codon 1643 is replaced by leucine, an amino acid with highly similar properties. This variant was reported in a case of sudden infant death along with variants in other cardiac-related genes; however, p.I1643L was also detected in relatives with normal cardiovascular screening (Campuzano O et al. Forensic Sci Int. 2014;242:9-15). This amino acid position is not well conserved in available vertebrate species, and leucine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at